Competition Agency is studying the Georgian pharmaceutical market to reveal monopolies
or cartel transactions. The businessmen believe that the research will not
reveal any violations of the law.
Kurtanidze, General Director of Aversi which is one of the country's largest
pharmaceutical companies, says that the Georgian pharmaceutical market has neither
monopolies nor cartels.
can study the pharmaceutical market which is distinguished with very high, tense and
intense competition,” he explains.
community, the media, NGOs have been talking about an unhealthy situation on
the pharmaceutical market for many years. The situation has not changed and three large companies continue to fully
control the import and distribution of drugs and completely dominate the local market.
say that enjoying a privileged position, pharmacy chains get excess profits
from the sale of drugs, sometimes selling them even with a 200-300% mark-up.
Aversi founder’s words, in 2019 drugs prices
will decline due to a decrease in their cost, but the prices of medicines are
still a serious problem for the population.
are constantly working on prices and every
year some medicines fall in price. We are in talks with
suppliers over the low prices for drugs, ” Paata Kurtanidze explains.